Article
Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
Annals of surgical oncology - 1 Sept 2021
Metcalfe Kelly A, Eisen Andrea, Poll Aletta, Candib Alexandra, McCready David, Cil Tulin, Wright Frances, Demsky Rochelle, Mancuso Talia, Sun Ping, Narod Steven A
Abstract excerpt
BACKGROUND: There is an increasing desire for contralateral prophylactic mastectomy (CPM) among patients with unilateral breast cancer. It is unknown if risk assessment and genetic testing at the time of diagnosis will aid women in their surgical choice. We report on the uptake and predictors of CPM in women receiving a negative genetic test result for BRCA1 and BRCA2 mutations before surgery. METHODS: Women...
Topics
- Adult
- Aged
- Aged, 80 and over
- BRCA1 Protein
- BRCA2 Protein
- Breast Neoplasms
- Female
- Genes, BRCA1
- Genes, BRCA2
- Genetic Testing
- Humans
- Mastectomy
- Middle Aged
- Mutation